T W Barrowcliffe

3.1k total citations · 1 hit paper
80 papers, 2.5k citations indexed

About

T W Barrowcliffe is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, T W Barrowcliffe has authored 80 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hematology, 23 papers in Surgery and 17 papers in Internal Medicine. Recurrent topics in T W Barrowcliffe's work include Hemophilia Treatment and Research (35 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (20 papers). T W Barrowcliffe is often cited by papers focused on Hemophilia Treatment and Research (35 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (20 papers). T W Barrowcliffe collaborates with scholars based in United Kingdom, Sweden and Italy. T W Barrowcliffe's co-authors include Edward A. Johnson, L.-O. Andersson, G.E.C. Sims, E. Holmer, Elaine Gray, Thomas B. L. Kirkwood, D P Thomas, Trevor Baglin, Duncan P. Thomas and M.W. Greaves and has published in prestigious journals such as The Lancet, Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

T W Barrowcliffe

80 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration

1976 381 citations T W Barrowcliffe et al. profile →

Peers

T W Barrowcliffe

HEMAT

IM

CCM

SURGE

CB

L. Bara France

John C. Hoak United States

Giuseppe G. Nenci Italy

M Dechavanne France

J Owen United States

D.G. Meuleman Netherlands

Vivien Chen Australia

D C Stump United States

Margaret L. Rand Canada

V. V. Kakkar United Kingdom

L. Bara France

T W Barrowcliffe

970 ×0.9

HEMAT

1.1k ×1.4

IM

2.3k ×3.2

CCM

955 ×1.7

SURGE

145 ×0.4

CB

Citations per year, relative to T W Barrowcliffe T W Barrowcliffe (= 1×) peers L. Bara

Countries citing papers authored by T W Barrowcliffe

Since Specialization

Citations

This map shows the geographic impact of T W Barrowcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T W Barrowcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T W Barrowcliffe more than expected).

Fields of papers citing papers by T W Barrowcliffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T W Barrowcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T W Barrowcliffe. The network helps show where T W Barrowcliffe may publish in the future.

Co-authorship network of co-authors of T W Barrowcliffe

This figure shows the co-authorship network connecting the top 25 collaborators of T W Barrowcliffe. A scholar is included among the top collaborators of T W Barrowcliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T W Barrowcliffe. T W Barrowcliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Barrowcliffe, T W. (2010). Insights from factor IX activation studies with chromogenic assays: implications of disparate product results. Haemophilia. 16(s6). 9–12. 11 indexed citations

2.

Harenberg, Job, A. K. Kakkar, D. BERGQVIST, et al.. (2009). Recommendations on biosimilar low‐molecular‐weight heparins. Journal of Thrombosis and Haemostasis. 7(7). 1222–1225. 26 indexed citations

3.

Pickering, W., Elaine Gray, Alison H. Goodall, & T W Barrowcliffe. (2008). Effects of apoptosis and lipid peroxidation on T‐lymphoblastoid phospholipid‐dependent procoagulant activity. Journal of Thrombosis and Haemostasis. 6(7). 1122–1130. 6 indexed citations

4.

Baglin, Trevor, T W Barrowcliffe, Alexander Cohen, & M.W. Greaves. (2006). Guidelines on the use and monitoring of heparin. British Journal of Haematology. 133(1). 19–34. 173 indexed citations

5.

Barrowcliffe, T W, Marco Cattaneo, Gian Marco Podda, et al.. (2006). New approaches for measuring coagulation. Haemophilia. 12(s3). 76–81. 39 indexed citations

6.

Yang, Xi, et al.. (2004). Relationships between factor VIII:Ag and factor VIII in recombinant and plasma‐derived factor VIII concentrates. Haemophilia. 10(5). 459–469. 40 indexed citations

7.

Baglin, Trevor, Isobel D. Walker, Samuel J. Machin, et al.. (1998). Guidelines on oral anticoagulation: third edition. British Journal of Haematology. 101(2). 374–387. 248 indexed citations

8.

Laposata, Michael, et al.. (1998). College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.. PubMed. 122(9). 799–807. 198 indexed citations

9.

Gray, Elaine, et al.. (1996). Inhibition of thrombin generation by heparin and LMW heparins. Blood Coagulation & Fibrinolysis. 7(1). 24–30. 15 indexed citations

10.

Barrowcliffe, T W. (1994). Potency issues with recombinant factor VIII. Annals of Hematology. 68(S3). S89–S91. 4 indexed citations

11.

Colvin, B T & T W Barrowcliffe. (1993). The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.. Journal of Clinical Pathology. 46(2). 97–103. 53 indexed citations

12.

Longstaff, Colin, et al.. (1993). Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III. Biochemistry. 32(28). 7286–7293. 25 indexed citations

13.

Giddings, J. C., M. Greaves, R A Hutton, et al.. (1991). Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.. Journal of Clinical Pathology. 44(11). 885–889. 59 indexed citations

14.

Dawes, J., et al.. (1990). High Molecular Weight Aggregate Content of Heated and Unheated Factor VIII Products Determined by Fast‐Protein Liquid Chromatography. Vox Sanguinis. 58(1). 30–34. 3 indexed citations

15.

Kemball‐Cook, Geoffrey, et al.. (1989). Assay Discrepancies with Highly Purified Factor VIII Concentrates. Pathophysiology of Haemostasis and Thrombosis. 19(3). 131–137. 27 indexed citations

16.

Barrowcliffe, T W & D P Thomas. (1989). Anticoagulant Activities of Heparin and Fragments. Annals of the New York Academy of Sciences. 556(1). 132–145. 13 indexed citations

17.

Kemball‐Cook, Geoffrey, et al.. (1988). Factor VIII Procoagulant Protein Interacts with Phospholipid Vesicles Via its 80 kDa Light Chain. Thrombosis and Haemostasis. 60(3). 442–446. 19 indexed citations

18.

Barrowcliffe, T W, J. Stocks, & Elaine Gray. (1982). Preparation of a Stable Phospholipid Reagent for Coagulation Assays. Pathophysiology of Haemostasis and Thrombosis. 11(2). 96–101. 12 indexed citations

19.

Nilsson, I. M., T W Barrowcliffe, Thomas B. L. Kirkwood, Maggie Miller-Andersson, & M.J. Seghatchian. (1977). Problems of Quantitation of F VIII:C Activity. Thrombosis and Haemostasis. 3 indexed citations

20.

Barrowcliffe, T W, et al.. (1972). Clotting factor concentrates.. BMJ. 1(5795). 309.2–310. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact